Rivero JL, Sporleder HP, Quiroz-Rothe E, Vervuert I, Coenen M, Harmeyer J
Their provider recommends adding semaglutide to address the weight gain
List of Most Commonly Encountered Drugs Currently Controlled under the Misuse of Drugs Legislation
While direct hepatic effects have been proposed, human hepatocyte GLP-1 receptor expression is limited, and most hepatic benefits correlate with weight loss and improved metabolic parameters rather than direct receptor-mediated effects
The evidence is strongest for improvements in weight, BMI, insulin resistance, waist circumference, and some androgen-related markers
The mean dosage of Liraglutide in these studies ranged from 0.78 mg to 3 mg daily, with an average dose of 1.75 mg daily